We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current CBIO market cap is 19.42M. The company's latest EPS is USD -2.4470 and P/E is -5.46.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 113.45M | 27.17M | 25.23M |
| Operating Income | -2.54M | -2.82M | -53.97M | 8.07M | 3.26M |
| Net Income | -2.47M | -1.58M | -89.15M | 7.53M | 3.53M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 20.95M | 7.34M | 794k | 113.45M |
| Operating Income | -57.28M | -57.37M | -87.89M | -65.8M | -63.89M |
| Net Income | -55.18M | -56.24M | -87.93M | -8.24M | -92.93M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 12.39M | 9.96M | 116.54M | 122.01M | 120.93M |
| Total Liabilities | 7.4M | 6.45M | 38.07M | 33.24M | 27.58M |
| Total Equity | -28.31M | 3.52M | 13.95M | 88.77M | 93.35M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 98.55M | 94.85M | 55.66M | 28.44M | 116.54M |
| Total Liabilities | 30.22M | 18.78M | 14.57M | 16.82M | 38.07M |
| Total Equity | 68.34M | 76.07M | 41.09M | -21.69M | 13.95M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -8.69M | -11.9M | 25.89M | 2.88M | -2.61M |
| Investing | 5.21M | 5.21M | -19.76M | -7.22M | -15.49M |
| Financing | -11.26M | -12.74M | 2.5M | 658k | 814k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -43.61M | -55.05M | -83.76M | -33.1M | 25.89M |
| Investing | 27.39M | 9.66M | 48.19M | 55.43M | -19.76M |
| Financing | 327k | 60.38M | 49.55M | -45.01M | 2.5M |
| Market Cap | 19.42M |
| Price to Earnings Ratio | -5.46 |
| Price to Sales Ratio | 4.47 |
| Price to Cash Ratio | 15.13 |
| Price to Book Ratio | 6.46 |
| Dividend Yield | - |
| Shares Outstanding | 37.98M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | 2.26% |
| 52 Week High | 0.588 |
| 52 Week Low | 0.32 |
| Spread (Intraday) | 0.05 (8.56%) |
| Company Name | Catalyst Biosciences Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.gyretx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
